Watch now:
Watch now:
View her responses here:
View her responses here:
He touched on technological shifts in radiology, dermatology, and more...
He touched on technological shifts in radiology, dermatology, and more...
In her on-camera discussion, Holzem was asked about her session ‘Difficult Cases & Red Flags in Dermatology: When to Admit From the Clinic.’
🔗View: www.hcplive.com/view/difficu...
In her on-camera discussion, Holzem was asked about her session ‘Difficult Cases & Red Flags in Dermatology: When to Admit From the Clinic.’
🔗View: www.hcplive.com/view/difficu...
He touched on technological shifts in radiology, dermatology, and more...
He touched on technological shifts in radiology, dermatology, and more...
HCPLive spoke with Jurgen Floege, MD, at Kidney Week 2025 about the emerging CD38-targeted therapy, felzartamab for sustained immunologic and symptomatic responses in adults with high-risk IgA Nephropathy.
Learn more:
HCPLive spoke with Jurgen Floege, MD, at Kidney Week 2025 about the emerging CD38-targeted therapy, felzartamab for sustained immunologic and symptomatic responses in adults with high-risk IgA Nephropathy.
Learn more: